ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Combined treatment with glucagon-like peptide-1 receptor agonist exendin-4 and metformin attenuates breast cancer growth
Diabetology International
◽
10.1007/s13340-021-00560-z
◽
2021
◽
Author(s):
Yuki Tanaka
◽
Chikayo Iwaya
◽
Takako Kawanami
◽
Yuriko Hamaguchi
◽
Tsuyoshi Horikawa
◽
...
Keyword(s):
Breast Cancer
◽
Receptor Agonist
◽
Combined Treatment
◽
Cancer Growth
◽
Glucagon Like Peptide
◽
Glucagon Like Peptide 1
◽
Breast Cancer Growth
Download Full-text
Related Documents
Cited By
References
Combined Treatment with Exendin-4 and Metformin Attenuates Breast Cancer Growth
Diabetes
◽
10.2337/db18-1227-p
◽
2018
◽
Vol 67
(Supplement 1)
◽
pp. 1227-P
Author(s):
CHIKAYO IWAYA
◽
TAKASHI NOMIYAMA
◽
TAKAKO KAWANAMI
◽
YURIKO HAMAGUCHI
◽
TOMOKO TANAKA
◽
...
Keyword(s):
Breast Cancer
◽
Combined Treatment
◽
Cancer Growth
◽
Breast Cancer Growth
Download Full-text
The Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exendin-4 Upregulates cAMP Levels, Activates AMP Kinase and Inhibits In Vitro and In Vivo Growth of Breast Cancer Cells.
10.1210/endo-meetings.2010.part3.p1.p3-45
◽
2010
◽
pp. P3-45-P3-45
Author(s):
Tamar Rubinek
◽
Hagai Ligumsky
◽
Avraham Karasik
◽
Ido Wolf
Keyword(s):
Breast Cancer
◽
Cancer Cells
◽
Receptor Agonist
◽
Amp Kinase
◽
Glucagon Like Peptide
◽
Glucagon Like Peptide 1
◽
In Vivo Growth
◽
Camp Levels
Download Full-text
Cardioprotective Benefits of Combined Treatment With Glucagon-Like Peptide-1 Receptor Agonist & Sodium Glucose Transporter-2 Inhibitor In Mice
Atherosclerosis Supplements
◽
10.1016/j.atherosclerosissup.2018.04.341
◽
2018
◽
Vol 32
◽
pp. 111
Author(s):
Dorrin Zarrin Khat
◽
Abdul Momen
◽
Muhammad A. Siraj
◽
Sina Hadipour-Lakmehsari
◽
Mark J. Chandy
◽
...
Keyword(s):
Receptor Agonist
◽
Glucose Transporter
◽
Combined Treatment
◽
Glucose Transporter 2
◽
Glucagon Like Peptide
◽
Glucagon Like Peptide 1
Download Full-text
1954-P: Combined Treatment with Exendin-4 and Metformin Attenuates Breast Cancer Growth
Diabetes
◽
10.2337/db19-1954-p
◽
2019
◽
Vol 68
(Supplement 1)
◽
pp. 1954-P
Author(s):
YUKI FUJIMURA
◽
TAKASHI NOMIYAMA
◽
CHIKAYO IWAYA
◽
TAKAKO KAWANAMI
◽
YURIKO HAMAGUCHI
◽
...
Keyword(s):
Breast Cancer
◽
Combined Treatment
◽
Cancer Growth
◽
Breast Cancer Growth
Download Full-text
Dulaglutide, a glucagon-like peptide-1 receptor agonist: in the search for survival molecule
Endocrinology: News, Opinions, Training
◽
10.33029/2304-9529-2020-9-2-49-58
◽
2020
◽
Vol 9
(2)
◽
pp. 49-58
Author(s):
A.S. Ametov
◽
◽
A.O. Nevolnikova
◽
E.A. Tertychnaya
◽
O.A. Mishra
◽
...
Keyword(s):
Receptor Agonist
◽
Glucagon Like Peptide
◽
Glucagon Like Peptide 1
Download Full-text
Liraglutide, a glucagon-like peptide-1 receptor agonist, improves bone mass and architecture in ovariectomised mice
Endocrine Abstracts
◽
10.1530/endoabs.34.p8
◽
2014
◽
Author(s):
Marie Pereira
◽
Jeshmi Jeyabalan
◽
Camilla Sofie Jorgensen
◽
Mark Cleasby
◽
Mark Hopkinson
◽
...
Keyword(s):
Bone Mass
◽
Receptor Agonist
◽
Glucagon Like Peptide
◽
Glucagon Like Peptide 1
Download Full-text
Patients with obesity caused by melanocortin-4 receptor mutations can be treated with a glucagon-like peptide-1 receptor agonist
Yearbook of Paediatric Endocrinology
◽
10.1530/ey.16.11.12
◽
2019
◽
Author(s):
Iepsen EW
◽
Zhang J
◽
Thomsen HS
◽
Hansen EL
◽
Hollensted M
◽
...
Keyword(s):
Receptor Agonist
◽
Melanocortin 4 Receptor
◽
Glucagon Like Peptide
◽
Glucagon Like Peptide 1
Download Full-text
Use of Big-Data Algorithms to Characterize Patients with T2D on Basal Insulin (BI) Who Add a Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) and Predict Their A1C Response
Diabetes
◽
10.2337/db18-100-lb
◽
2018
◽
Vol 67
(Supplement 1)
◽
pp. 100-LB
◽
Cited By ~ 1
Author(s):
ESTHER ZIMMERMANN
◽
ADAM LENART
◽
JOAO DIOGO DA ROCHA FERNANDES
◽
SARAH EGGERT
◽
MATTIS F. RANTHE
Keyword(s):
Big Data
◽
Basal Insulin
◽
Receptor Agonist
◽
Glucagon Like Peptide
◽
Glucagon Like Peptide 1
Download Full-text
Combination of Premixed Insulin with Glucagon-Like Peptide-1 Receptor Agonist (GLP-1) for Uncontrolled Type 2 Diabetes Mellitus (T2DM) Patients
Diabetes
◽
10.2337/db18-2231-pub
◽
2018
◽
Vol 67
(Supplement 1)
◽
pp. 2231-PUB
Author(s):
SASAN FAZELI
◽
NICOLE EHRHARDT
Keyword(s):
Diabetes Mellitus
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Receptor Agonist
◽
Premixed Insulin
◽
Glucagon Like Peptide
◽
Glucagon Like Peptide 1
Download Full-text
Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Attenuates Prostate Cancer Cell Proliferation via Phosphorylation of MKP-1
Diabetes
◽
10.2337/db18-1957-p
◽
2018
◽
Vol 67
(Supplement 1)
◽
pp. 1957-P
Author(s):
TAKAKO KAWANAMI
◽
TAKASHI NOMIYAMA
◽
YURIKO HAMAGUCHI
◽
TOMOKO TANAKA
◽
TOSHIHIKO YANASE
Keyword(s):
Prostate Cancer
◽
Cell Proliferation
◽
Cancer Cell
◽
Receptor Agonist
◽
Prostate Cancer Cell
◽
Cancer Cell Proliferation
◽
Glucagon Like Peptide
◽
Glucagon Like Peptide 1
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close